HOME > BUSINESS > Article

Text Size

small

medium

large


Takeda's Shire Acquisition Seen Opposed by Some Founding Family Members

Takeda's Shire Acquisition Seen Opposed by Some Founding Family Members

   Tokyo, Dec. 3 (Jiji Press)--Some members of the founding family of Takeda Pharmaceutical Co. <4502> have become opposed to the leading Japanese drug maker's plan to acquire Irish industry peer Shire PLC for roughly 7 trillion yen, a member of the family suggested Monday.
   The Shire acquisition involves financial risks that are "too great" for "quite limited" benefits, founding family member and former senior Takeda official Kazuhisa Takeda, 78, told a press conference at the Foreign Correspondents' Club of Japan in Tokyo.

To read a full story, please click here to find out how to subscribe.

BUSINESS

HEADLINES

POLITICS
Japan Remains Committed to Defense-Oriented Policy, Minister Iwaya Says
ECONOMY
Japan Post Holdings Says It Will Acquire Some 7% Stake in Aflac in 2019
SPORTS
Baseball: Yomiuri Signs Ex-Major Leaguer Hisashi Iwakuma to 1-Year Deal
OTHER
Japan's Top Court Finds Vote-Value Gaps in 2017 General Election Constitutional

AFP-JIJI PRESS NEWS JOURNAL


Photos